HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Tennessee AG Challenges Local PSE Prescription Laws

This article was originally published in The Tan Sheet

Executive Summary

Tennessee AG Robert Cooper pushes back against local ordinances to require prescriptions for pseudoephedrine. Acura Pharmaceuticals says stricter local laws could block potential extraction-resistant products from OTC sale.

You may also be interested in...



Rx-Only Pseudoephedrine Stalls As Meth Solution In Tennessee, Indiana

Tennessee’s meth lab seizures are up this year, but CHPA says that’s because more labs are uncovered through the state’s participation in the NPLEx stop-sale system. Rx-only bills have stalled in several states, including Indiana, where lawmakers passed a bill to cap PSE purchases at about 61 grams per year.

In Brief

Okla. AG opposes local Rx-only PSE laws

OTC Pseudoephedrine Purchases In Arkansas Require In-State Identification

An Arkansas law limits sales of pseudoephedrine-containing OTC products to consumers with in-state identification, pioneering a tactic in states' attempts to curb illegal purchases.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS123988

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel